Kv7.2

1

Gafar H et al. Membrane coordination of receptors and channels mediating the inhibition of neuronal ion currents by ADP.
Purinergic Signal., 2016 May 12 , ().

2

Dai G et al. Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.
Proc. Natl. Acad. Sci. U.S.A., 2016 Jun 7 , 113 (E3290-9).

3

Kumar M et al. Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.
Mol. Pharmacol., 2016 Jun , 89 (667-77).

4

Schütze S et al. KCNQ Potassium Channels Modulate Sensitivity of Skin D-hair Mechanoreceptors.
J. Biol. Chem., 2016 Jan 5 , ().

5

Syeda R et al. The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.
J. Biol. Chem., 2016 Feb 5 , 291 (2931-7).

6

Benned-Jensen T et al. Live Imaging of Kv7.2/7.3 Cell Surface Dynamics at the Axon Initial Segment: High Steady-State Stability and Calpain-Dependent Excitotoxic Downregulation Revealed.
J. Neurosci., 2016 Feb 17 , 36 (2261-6).

7

Kim KX et al. Maturation of NaV and KV Channel Topographies in the Auditory Nerve Spike Initiator before and after Developmental Onset of Hearing Function.
J. Neurosci., 2016 Feb 17 , 36 (2111-8).

8

Siloni S et al. Regulation of the neuronal KCNQ2 channel by Src--a dual rearrangement of the cytosolic termini underlies bidirectional regulation of gating.
J. Cell. Sci., 2015 Sep 15 , 128 (3489-501).

9

Alberdi A et al. Uncoupling PIP2-calmodulin regulation of Kv7.2 channels by an assembly de-stabilizing epileptogenic mutation.
J. Cell. Sci., 2015 Sep 10 , ().

10

Samanta D et al. Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation.
Acta Neurol Belg, 2015 Sep , 115 (475-8).

11

Provence A et al. The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.
J. Pharmacol. Exp. Ther., 2015 Sep , 354 (290-301).

12

Reid ES et al. Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6.
JIMD Rep, 2015 Oct 8 , ().

13

Jiang L et al. Activation of m1 muscarinic acetylcholine receptor induces surface transport of KCNQ channel via CRMP-2 mediated pathway.
J. Cell. Sci., 2015 Oct 7 , ().

14

Santella L et al. Assisted yes, but where do we draw the line?
Reprod. Biomed. Online, 2015 Oct , 31 (476-8).

15

Barrese V et al. Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices.
J. Cereb. Blood Flow Metab., 2015 Oct , 35 (1593-600).

16

Milh M et al. Variable clinical expression in patients with mosaicism for KCNQ2 mutations.
Am. J. Med. Genet. A, 2015 Oct , 167A (2314-8).

17

Davoren JE et al. Discovery of a novel Kv7 channel opener as a treatment for epilepsy.
Bioorg. Med. Chem. Lett., 2015 Nov 1 , 25 (4941-4).

18

Pribaz E et al. The Jack Pribaz Foundation and KCNQ2.org.
Epilepsia, 2015 May , 56 (682-4).

19

Pisano T et al. Early and effective treatment of KCNQ2 encephalopathy.
Epilepsia, 2015 May , 56 (685-91).

20

Mercimek-Mahmutoglu S et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Epilepsia, 2015 May , 56 (707-16).

21

Kaminsky Z et al. DNA methylation and expression of KCNQ3 in bipolar disorder.
Bipolar Disord, 2015 Mar , 17 (150-9).

22

Kalappa BI et al. Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus.
J. Neurosci., 2015 Jun 10 , 35 (8829-42).

23

Okumura A et al. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4.
Epileptic Disord, 2015 Jun , 17 (165-71).

24

Mills TA et al. Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries.
Placenta, 2015 Jun , 36 (638-44).

25

Xu M et al. An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels.
J. Biol. Chem., 2015 Jul 3 , 290 (16619-32).

26

Grinton BE et al. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome.
Epilepsia, 2015 Jul , 56 (1071-80).

27

Martinello K et al. Cholinergic afferent stimulation induces axonal function plasticity in adult hippocampal granule cells.
Neuron, 2015 Jan 21 , 85 (346-63).

28

Miceli F et al. A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability.
Epilepsia, 2015 Feb , 56 (e15-20).

29

Lemmerhirt CJ et al. Oxidation potentials of N-modified derivatives of the analgesic flupirtine linked to potassium KV 7 channel opening activity but not hepatocyte toxicity.
ChemMedChem, 2015 Feb , 10 (368-79).

30

Boutry-Kryza N et al. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome.
Eur J Med Genet, 2015 Feb , 58 (51-8).

31

Hashimoto R et al. Uncompacted Myelin Lamellae and Nodal Ion Channel Disruption in POEMS Syndrome.
J. Neuropathol. Exp. Neurol., 2015 Dec , 74 (1127-36).

32

Laumet G et al. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.
Nat. Neurosci., 2015 Dec , 18 (1746-55).

33

Wang J et al. Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy.
Brain Res., 2015 Aug 7 , 1616 (112-22).

34

Gomis-Perez C et al. An unconventional calmodulin-anchoring site within the AB module of Kv7.2 channels.
J. Cell. Sci., 2015 Aug 15 , 128 (3155-63).

35

Abidi A et al. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
Neurobiol. Dis., 2015 Aug , 80 (80-92).

36

Li C et al. Activity-dependent downregulation of M-Type (Kv7) K⁺ channels surface expression requires the activation of iGluRs/Ca²⁺/PKC signaling pathway in hippocampal neuron.
Neuropharmacology, 2015 Aug , 95 (154-67).

37

Figueiro-Silva J et al. Neuronal pentraxin 1 negatively regulates excitatory synapse density and synaptic plasticity.
J. Neurosci., 2015 Apr 8 , 35 (5504-21).

38

Svalø J et al. Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction.
PLoS ONE, 2015 , 10 (e0117350).

39

Fidzinski P et al. KCNQ5 K(+) channels control hippocampal synaptic inhibition and fast network oscillations.
Nat Commun, 2015 , 6 (6254).

40

Kim RY et al. Atomic basis for therapeutic activation of neuronal potassium channels.
Nat Commun, 2015 , 6 (8116).

41

Mayordomo-Cava J et al. Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus.
PLoS ONE, 2015 , 10 (e0134385).

42

Zhang F et al. Inhibition of Kv7/M Channel Currents by the Local Anesthetic Chloroprocaine.
Pharmacology, 2015 , 96 (124-30).

43

Shimatani Y et al. Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome.
Clin Neurophysiol, 2014 Sep 28 , ().

44

Cuppoletti J et al. Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.
Am. J. Physiol., Cell Physiol., 2014 Sep 1 , 307 (C479-92).

45

Allen NM et al. The variable phenotypes of KCNQ-related epilepsy.
Epilepsia, 2014 Sep , 55 (e99-105).

46

Zerem A et al. Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings.
Eur. J. Paediatr. Neurol., 2014 Sep , 18 (567-71).

47

Grigorov A et al. Kv7 potassium channel subunits and M currents in cultured hippocampal interneurons.
Pflugers Arch., 2014 Sep , 466 (1747-58).

48

King CH et al. Kv7.2 regulates the function of peripheral sensory neurons.
J. Comp. Neurol., 2014 Oct 1 , 522 (3262-80).

49

Li C et al. KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
Neuroscience, 2014 Nov 7 , 280 (19-30).

50

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

51

Battefeld A et al. Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons.
J. Neurosci., 2014 Mar 5 , 34 (3719-32).

52

Brueggemann LI et al. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Am. J. Physiol. Lung Cell Mol. Physiol., 2014 Mar 15 , 306 (L476-86).

53

Orhan G et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.
Ann. Neurol., 2014 Mar , 75 (382-94).

54

Soldovieri MV et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A.
Hum. Mutat., 2014 Mar , 35 (356-67).

55

Jepps TA et al. Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370.
Br. J. Pharmacol., 2014 Jun 9 , ().

56

Dickson EJ et al. Golgi and plasma membrane pools of PI(4)P contribute to plasma membrane PI(4,5)P2 and maintenance of KCNQ2/3 ion channel current.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jun 3 , 111 (E2281-90).

57

Brueggemann LI et al. Differential Activation of Vascular Smooth Muscle Kv7.4, Kv7.5, and Kv7.4/7.5 Channels by ML213 and ICA-069673.
Mol. Pharmacol., 2014 Jun 18 , ().

58

Martin HC et al. Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.
Hum. Mol. Genet., 2014 Jun 15 , 23 (3200-11).

59

Numis AL et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response.
Neurology, 2014 Jan 28 , 82 (368-70).

60

Liu W et al. Calmodulin orchestrates the heteromeric assembly and the trafficking of KCNQ2/3 (Kv7.2/3) channels in neurons.
Mol. Cell. Neurosci., 2014 Jan , 58 (40-52).

61

Gourgy-Hacohen O et al. Capturing distinct KCNQ2 channel resting states by metal ion bridges in the voltage-sensor domain.
J. Gen. Physiol., 2014 Dec , 144 (513-27).

62

Li P et al. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
J. Pharmacol. Exp. Ther., 2014 Dec , 351 (596-604).

63

Soh H et al. Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability.
J. Neurosci., 2014 Apr 9 , 34 (5311-21).

64

Kang S et al. Channel-anchored protein kinase CK2 and protein phosphatase 1 reciprocally regulate KCNQ2-containing M-channels via phosphorylation of calmodulin.
J. Biol. Chem., 2014 Apr 18 , 289 (11536-44).

65

Soh H et al. Cortical KCNQ2/3 channels; insights from knockout mice.
Channels (Austin), 2014 , 8 (389-90).

66

Kole MH et al. Axonal Kv7.2/7.3 channels: caught in the act.
Channels (Austin), 2014 , 8 (288-9).

67

Moreau A et al. Biophysics, pathophysiology, and pharmacology of ion channel gating pores.
Front Pharmacol, 2014 , 5 (53).

68

Hille B et al. Dynamic metabolic control of an ion channel.
Prog Mol Biol Transl Sci, 2014 , 123 (219-47).

69

Dalen Meurs-van der Schoor C et al. Severe Neonatal Epileptic Encephalopathy and KCNQ2 Mutation: Neuropathological Substrate?
Front Pediatr, 2014 , 2 (136).

70

Tomonoh Y et al. The kick-in system: a novel rapid knock-in strategy.
PLoS ONE, 2014 , 9 (e88549).

71

Achary PG Simplified molecular input line entry system-based optimal descriptors: QSAR modelling for voltage-gated potassium channel subunit Kv7.2.
SAR QSAR Environ Res, 2014 , 25 (73-90).

72

Wu C et al. Kcnq1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish.
BMC Physiol., 2014 , 14 (1).

73

Alaimo A et al. Pivoting between calmodulin lobes triggered by calcium in the Kv7.2/calmodulin complex.
PLoS ONE, 2014 , 9 (e86711).

74

Maljevic S et al. Potassium channel genes and benign familial neonatal epilepsy.
Prog. Brain Res., 2014 , 213 (17-53).

75

Blom SM et al. From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group.
PLoS ONE, 2014 , 9 (e100209).

76

Cavaretta JP et al. Polarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit.
PLoS ONE, 2014 , 9 (e103655).

77

[To the mechanisms of antiarrhythmic action of Allapinine].
Bioorg. Khim., 2013 Jan-Feb , 39 (105-16).

78

Svalø J et al. Bladder contractility is modulated by Kv7 channels in pig detrusor.
Eur. J. Pharmacol., 2013 Sep 5 , 715 (312-20).

79

Kornilov P et al. Channel gating pore: a new therapeutic target.
Cell Res., 2013 Sep , 23 (1067-8).

80

Li P et al. The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands.
Cell Res., 2013 Sep , 23 (1106-18).

81

Reilly JM et al. Kv7/M-type potassium channels in rat skin keratinocytes.
Pflugers Arch., 2013 Sep , 465 (1371-81).

82

Vetter I et al. Amplified cold transduction in native nociceptors by M-channel inhibition.
J. Neurosci., 2013 Oct 16 , 33 (16627-41).

83

Salyer SA et al. Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells.
Biochim. Biophys. Acta, 2013 Oct , 1832 (1734-43).

84

Hu HN et al. Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels.
Acta Pharmacol. Sin., 2013 Oct , 34 (1359-66).

85

Li X et al. Millimeter wave promotes the synthesis of extracellular matrix and the proliferation of chondrocyte by regulating the voltage-gated K(+) channel.
J. Bone Miner. Metab., 2013 Nov 8 , ().

86

Weckhuysen S et al. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.
Neurology, 2013 Nov 5 , 81 (1697-703).

87

Wu YJ et al. Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Bioorg. Med. Chem. Lett., 2013 Nov 15 , 23 (6188-91).

88

Walleigh DJ et al. Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine.
Pediatr. Neurol., 2013 Nov , 49 (368-9).

89

Morhenn VB et al. Psoriatic keratinocytes are resistant to tumor necrosis factor alpha's induction of mRNA for the NMDA-R2C subunit.
Exp. Dermatol., 2013 Nov , 22 (750-1).

90

Zhou P et al. Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
Proc. Natl. Acad. Sci. U.S.A., 2013 May 21 , 110 (8726-31).

91

Fister P et al. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: a European case.
Eur. J. Paediatr. Neurol., 2013 May , 17 (308-10).

92

Cuppoletti J et al. Methadone but not morphine inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents.
Cell Biochem. Biophys., 2013 May , 66 (53-63).

93

Falkenburger BH et al. Quantitative properties and receptor reserve of the DAG and PKC branch of G(q)-coupled receptor signaling.
J. Gen. Physiol., 2013 May , 141 (537-55).

94

Dickson EJ et al. Quantitative properties and receptor reserve of the IP(3) and calcium branch of G(q)-coupled receptor signaling.
J. Gen. Physiol., 2013 May , 141 (521-35).

95

Zara F et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
Epilepsia, 2013 Mar , 54 (425-36).

96

Zheng Q et al. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model.
Pain, 2013 Mar , 154 (434-48).

97

Boehlen A et al. The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.
Br. J. Pharmacol., 2013 Mar , 168 (1182-200).

98

Li P et al. The ethylene bis-dithiocarbamate fungicide Mancozeb activates voltage-gated KCNQ2 potassium channel.
Toxicol. Lett., 2013 Jun 7 , 219 (211-7).

99

Sander SE et al. The K(V)7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats.
Neurosci. Lett., 2013 Jun 17 , 545 (59-63).

100

Li S et al. Pathogenic plasticity of Kv7.2/3 channel activity is essential for the induction of tinnitus.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jun 11 , 110 (9980-5).

101

Serino D et al. Video/EEG findings in a KCNQ2 epileptic encephalopathy: a case report and revision of literature data.
Epileptic Disord, 2013 Jun , 15 (158-65).

102

Füll Y et al. A conserved threonine in the S1-S2 loop of KV7.2 and K V7.3 channels regulates voltage-dependent activation.
Pflugers Arch., 2013 Jun , 465 (797-804).

103

Kato M et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.
Epilepsia, 2013 Jul , 54 (1282-7).

104

Telezhkin V et al. A basic residue in the proximal C-terminus is necessary for efficient activation of the M-channel subunit Kv7.2 by PI(4,5)P₂.
Pflugers Arch., 2013 Jul , 465 (945-53).

105

Fretwell LV et al. Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.
Br. J. Pharmacol., 2013 Jul , 169 (1279-89).

106

Alaimo A et al. Cooperativity between calmodulin-binding sites in Kv7.2 channels.
J. Cell. Sci., 2013 Jan 1 , 126 (244-53).

107

Saadeldin IY et al. Novel KCNQ2 mutation in a large Emirati family with benign familial neonatal seizures.
Pediatr. Neurol., 2013 Jan , 48 (63-6).

108

Yoshimura S et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
J. Neurol. Neurosurg. Psychiatr., 2013 Jan , 84 (29-34).

109

Miranda P et al. The neuronal serum- and glucocorticoid-regulated kinase 1.1 reduces neuronal excitability and protects against seizures through upregulation of the M-current.
J. Neurosci., 2013 Feb 6 , 33 (2684-96).

110

Zhang XF et al. Development and validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel openers using QPatch HT.
Assay Drug Dev Technol, 2013 Feb , 11 (17-24).

111

Zhang Q et al. Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating.
Proc. Natl. Acad. Sci. U.S.A., 2013 Dec 10 , 110 (20093-8).

112

Khanamiri S et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia.
Hypertension, 2013 Dec , 62 (1090-7).

113

Lee YH et al. Pathway analysis of a genome-wide association study in schizophrenia.
Gene, 2013 Aug 1 , 525 (107-15).

114

Maslarova A et al. Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.
Neurobiol. Dis., 2013 Aug , 56 (14-24).

115

Lichter-Peled A et al. Role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals.
Vet. J., 2013 Apr , 196 (57-63).

116

Mi Y et al. The role of potassium channel activation in celecoxib-induced analgesic action.
PLoS ONE, 2013 , 8 (e54797).

117

Judy JT et al. Converging Evidence for Epistasis between ANK3 and Potassium Channel Gene KCNQ2 in Bipolar Disorder.
Front Genet, 2013 , 4 (87).

118

Glasgow SD et al. Muscarinic depolarization of layer II neurons of the parasubiculum.
PLoS ONE, 2013 , 8 (e58901).

119

Bennett V et al. Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates.
Curr Top Membr, 2013 , 72 (1-37).

120

Milh M et al. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.
Orphanet J Rare Dis, 2013 , 8 (80).

121

Cavaliere S et al. KCNQ channels regulate age-related memory impairment.
PLoS ONE, 2013 , 8 (e62445).

122

Afeli SA et al. Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.
PLoS ONE, 2013 , 8 (e75875).

123

Robbins J et al. Effects of KCNQ2 gene truncation on M-type Kv7 potassium currents.
PLoS ONE, 2013 , 8 (e71809).

124

Dai X et al. Effects of estrogen on neuronal KCNQ2/3 channels expressed in PC-12 cells.
Biol. Pharm. Bull., 2013 , 36 (1583-6).

125

Kosenko A et al. A change in configuration of the calmodulin-KCNQ channel complex underlies Ca2+-dependent modulation of KCNQ channel activity.
PLoS ONE, 2013 , 8 (e82290).

126

Ferrer T et al. Tamoxifen inhibition of kv7.2/kv7.3 channels.
PLoS ONE, 2013 , 8 (e76085).

127

Mattmann ME et al. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.
Bioorg. Med. Chem. Lett., 2012 Sep 15 , 22 (5936-41).

128

Yang ZM et al. [Study on gene differential expressions of substance and energy metabolism in chronic superficial gastritis patients of Pi deficiency syndrome and of pi-wei hygropyrexia syndrome].
Zhongguo Zhong Xi Yi Jie He Za Zhi, 2012 Sep , 32 (1180-7).

129

Tomlinson SE et al. In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.
Brain, 2012 Oct , 135 (3144-52).

130

Afawi Z et al. Benign neonatal sleep myoclonus: an autosomal dominant form not allelic to KCNQ2 or KCNQ3.
J. Child Neurol., 2012 Oct , 27 (1260-3).

131

Ishii A et al. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2.
Epilepsy Res., 2012 Nov , 102 (122-5).

132

Kosenko A et al. Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation.
, 2012 May 29 , ().

133

Telezhkin V et al. Structural requirements of membrane phospholipids for M-type potassium channel activation and binding.
J. Biol. Chem., 2012 Mar 23 , 287 (10001-12).

134

Hobiger K et al. Coupling of Ci-VSP modules requires a combination of structure and electrostatics within the linker.
Biophys. J., 2012 Mar 21 , 102 (1313-22).

135

Shah MM et al. HCN and K(V)7 (M-) channels as targets for epilepsy treatment.
, 2012 Mar 15 , ().

136

Pattnaik BR et al. Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Am. J. Physiol., Cell Physiol., 2012 Mar , 302 (C821-33).

137

Choveau FS et al. Pore helix-S6 interactions are critical in governing current amplitudes of KCNQ3 K+ channels.
Biophys. J., 2012 Jun 6 , 102 (2499-509).

138

Choveau FS et al. Pore determinants of KCNQ3 K+ current expression.
Biophys. J., 2012 Jun 6 , 102 (2489-98).

139

Ebner-Bennatan S et al. Multi-faceted modulation of K+ channels by protein tyrosine phosphatase epsilon tunes neuronal excitability.
, 2012 Jun 21 , ().

140

King CH et al. Kv7.5 is the primary Kv7 subunit expressed in C-fibers.
J. Comp. Neurol., 2012 Jun 15 , 520 (1940-50).

141

Li P et al. Comparison of the effects of DC031050, a class III antiarrhythmic agent, on hERG channel and three neuronal potassium channels.
Acta Pharmacol. Sin., 2012 Jun , 33 (728-36).

142

Van Poucke M et al. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers.
Neuromuscul. Disord., 2012 Jun , 22 (558-65).

143

Telezhkin V et al. Distinct subunit contributions to the activation of M-type potassium channels by PI(4,5)P2.
J. Gen. Physiol., 2012 Jul , 140 (41-53).

144

Blumkin L et al. Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation.
Eur. J. Paediatr. Neurol., 2012 Jul , 16 (356-60).

145

Gunthorpe MJ et al. The mechanism of action of retigabine (ezogabine), a first-in-class K(+) channel opener for the treatment of epilepsy.
, 2012 Jan 5 , ().

146

Brueggemann LI et al. Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.
Am. J. Physiol. Lung Cell Mol. Physiol., 2012 Jan , 302 (L120-32).

147

Weckhuysen S et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
Ann. Neurol., 2012 Jan , 71 (15-25).

148

Kamoun FF et al. Frontal motor seizure following non-convulsive status epilepticus in ring chromosome 20 syndrome.
Neurosciences (Riyadh), 2012 Jan , 17 (74-7).

149

Hjaeresen ML et al. Time course and duration of changes in Kv7.2 and Kv11.1 mRNA expression in the hippocampus and piriform cortex following electroconvulsive stimulations.
Brain Stimul, 2012 Jan , 5 (55-60).

150

Linley JE et al. M channel enhancers and physiological M channel block.
J. Physiol. (Lond.), 2012 Feb 15 , 590 (793-807).

151

Mahoney K et al. High incidence of pediatric idiopathic epilepsy is associated with familial and autosomal dominant disease in Eastern Newfoundland.
Epilepsy Res., 2012 Feb , 98 (140-7).

152

Chege SW et al. Expression and function of KCNQ channels in larval zebrafish.
Dev Neurobiol, 2012 Feb , 72 (186-98).

153

Zhang J et al. Activity-dependent transcriptional regulation of M-Type (Kv7) K(+) channels by AKAP79/150-mediated NFAT actions.
Neuron, 2012 Dec 20 , 76 (1133-46).

154

Mefford HC et al. Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy.
Am. J. Med. Genet. A, 2012 Dec , 158A (3190-5).

155

Cheung YY et al. Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent,
J. Med. Chem., 2012 Aug 9 , 55 (6975-9).

156

Idevall-Hagren O et al. Optogenetic control of phosphoinositide metabolism.
Proc. Natl. Acad. Sci. U.S.A., 2012 Aug 28 , 109 (E2316-23).

157

Bocksteins E et al. Kv3 channels contribute to the delayed rectifier current in small cultured mouse dorsal root ganglion neurons.
Am. J. Physiol., Cell Physiol., 2012 Aug 15 , 303 (C406-15).

158

Saitsu H et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome.
Ann. Neurol., 2012 Aug , 72 (298-300).

159

Stewart AP et al. The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement.
J. Biol. Chem., 2012 Apr 6 , 287 (11870-7).

160

Brickel N et al. The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Epilepsia, 2012 Apr , 53 (606-12).

161

Sánchez-Ponce D et al. Developmental expression of Kv potassium channels at the axon initial segment of cultured hippocampal neurons.
PLoS ONE, 2012 , 7 (e48557).

162

Cavaliere S et al. KCNQ channels show conserved ethanol block and function in ethanol behaviour.
PLoS ONE, 2012 , 7 (e50279).

163

Yoshimura S et al. Genetic and infectious profiles of Japanese multiple sclerosis patients.
PLoS ONE, 2012 , 7 (e48592).

164

Aivar P et al. Surface expression and subunit specific control of steady protein levels by the Kv7.2 helix A-B linker.
PLoS ONE, 2012 , 7 (e47263).

165

Miller M et al. Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
J. Biol. Chem., 2011 Sep 23 , 286 (33436-46).

166

Etzioni A et al. Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A.
J. Neurosci., 2011 Oct 5 , 31 (14158-71).

167

Klinger F et al. Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus.
Neuroimage, 2011 Oct 1 , 58 (761-9).

168

Chen X et al. Membrane depolarization increases membrane PtdIns(4,5)P2 levels through mechanisms involving PKC βII and PI4 kinase.
J. Biol. Chem., 2011 Nov 18 , 286 (39760-7).

169

Hsieh YY et al. XRCC1 399 * Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194Arg, KCNQ2, AT1R, and hOGG1 polymorphisms, are associated with higher susceptibility of endometriosis.
, 2011 Nov 15 , ().

170

Jensen MM et al. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Basic Clin. Pharmacol. Toxicol., 2011 Nov , 109 (339-42).

171

Lobarinas E et al. Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats.
, 2011 May 27 , ().

172

Du X et al. Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels.
, 2011 May 13 , ().

173

Zhang J et al. AKAP79/150 Signal Complexes in G-Protein Modulation of Neuronal Ion Channels.
J. Neurosci., 2011 May 11 , 31 (7199-211).

174

Mulley JC et al. Epilepsy and the new cytogenetics.
Epilepsia, 2011 Mar , 52 (423-32).

175

Qi J et al. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Eur J Med Chem, 2011 Mar , 46 (934-43).

176

Zhou X et al. Novel role of KCNQ2/3 channels in regulating neuronal cell viability.
Cell Death Differ., 2011 Mar , 18 (493-505).

177

Zhou X et al. Potential role of KCNQ/M-channels in regulating neuronal differentiation in mouse hippocampal and embryonic stem cell-derived neuronal cultures.
Exp. Neurol., 2011 Jun , 229 (471-83).

178

Kristensen LV et al. Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Neurosci. Lett., 2011 Jan 20 , 488 (178-82).

179

Su J et al. A novel degradation signal derived from distal C-terminal frameshift mutations of KCNQ2 protein which cause neonatal epilepsy.
J. Biol. Chem., 2011 Dec 16 , 286 (42949-58).

180

Zhang D et al. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
J. Neurosci. Methods, 2011 Aug 30 , 200 (54-62).

181

Jepps TA et al. Downregulation of Kv7.4 channel activity in primary and secondary hypertension.
Circulation, 2011 Aug 2 , 124 (602-11).

182

Roepke TA et al. Fasting and 17β-estradiol differentially modulate the M-current in neuropeptide Y neurons.
J. Neurosci., 2011 Aug 17 , 31 (11825-35).

183

Larsen AP et al. Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state.
Biophys. J., 2011 Aug 17 , 101 (818-27).

184

Zhang XF et al. Coexpression and activation of TRPV1 suppress the activity of the KCNQ2/3 channel.
, 2011 Aug 15 , ().

185

Zhou XH et al. [Site-directed mutagenesis and protein expression of KCNQ2 gene associated with neonatal convulsions].
Zhongguo Dang Dai Er Ke Za Zhi, 2011 Aug , 13 (611-6).

186

Fortin DL et al. Optogenetic photochemical control of designer K+ channels in mammalian neurons.
, 2011 Apr 27 , ().

187

Rose K et al. Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury.
Pain, 2011 Apr , 152 (742-54).

188

Cooper EC Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons.
Semin. Cell Dev. Biol., 2011 Apr , 22 (185-92).

189

Jia C et al. Activation of KCNQ2/3 potassium channels by novel pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives.
Pharmacology, 2011 , 87 (297-310).

190

Roza C et al. Accumulation of Kv7.2 channels in putative ectopic transduction zones of mice nerve-end neuromas.
Mol Pain, 2011 , 7 (58).

191

Wang W et al. K(V)7/KCNQ channels are functionally expressed in oligodendrocyte progenitor cells.
PLoS ONE, 2011 , 6 (e21792).

192

Gómez-Posada JC et al. Kv7 channels can function without constitutive calmodulin tethering.
PLoS ONE, 2011 , 6 (e25508).

193

Cavaliere S et al. Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels.
PLoS ONE, 2011 , 6 (e23898).

194

Bi Y et al. Visceral hyperalgesia induced by forebrain-specific suppression of native Kv7/KCNQ/M-current in mice.
Mol Pain, 2011 , 7 (84).

195

Hoestgaard-Jensen K et al. Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors.
Neuropharmacology, 2010 Mar-Apr , 58 (702-11).

196

Gao Z et al. Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions.
J. Biol. Chem., 2010 Sep 3 , 285 (28322-32).

197

Ng FL et al. Expression and function of the K(+) channel KCNQ genes in human arteries.
, 2010 Sep 14 , ().

198

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

199

Heron SE et al. Familial neonatal seizures with intellectual disability caused by a microduplication of chromosome 2q24.3.
Epilepsia, 2010 Sep , 51 (1865-9).

200

Mucha M et al. Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability.
J. Neurosci., 2010 Oct 6 , 30 (13235-45).

201

Devaux J The C-terminal domain of aIV-spectrin is crucial for KCNQ2 aggregation and excitability at nodes of Ranvier.
, 2010 Oct 20 , ().

202

Lötsch J et al. Pharmacogenetics of new analgesics.
, 2010 Oct 13 , ().

203

Beacham DW et al. Cell-Based Potassium Ion Channel Screening Using the FluxORTM Assay.
, 2010 Mar 5 , ().

204

Kapfhamer D et al. Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity.
J. Neurosci., 2010 Jun 30 , 30 (8830-40).

205

Tzingounis AV et al. The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jun 1 , 107 (10232-7).

206

Meisler MH et al. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects.
J. Physiol. (Lond.), 2010 Jun 1 , 588 (1841-8).

207

Gómez-Posada JC et al. A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression.
J. Neurosci., 2010 Jul 7 , 30 (9316-23).

208

Fritch PC et al. Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.
J. Med. Chem., 2010 Jan 28 , 53 (887-96).

209

Hoshi N et al. Interaction with AKAP79 modifies the cellular pharmacology of PKC.
Mol. Cell, 2010 Feb 26 , 37 (541-50).

210

Bal M et al. Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels.
J. Neurosci., 2010 Feb 10 , 30 (2311-23).

211

Falkenburger BH et al. Kinetics of PIP2 metabolism and KCNQ2/3 channel regulation studied with a voltage-sensitive phosphatase in living cells.
J. Gen. Physiol., 2010 Feb , 135 (99-114).

212

Falkenburger BH et al. Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells.
J. Gen. Physiol., 2010 Feb , 135 (81-97).

213

Yum MS et al. The first Korean case of KCNQ2 mutation in a family with benign familial neonatal convulsions.
J. Korean Med. Sci., 2010 Feb , 25 (324-6).

214

Hawkins NA et al. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
, 2010 Dec 13 , ().

215

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Clin. Lab. Med., 2010 Dec , 30 (911-29).

216

Soh H et al. The specific slow afterhyperpolarization inhibitor UCL2077 is a subtype-selective blocker of the epilepsy associated KCNQ channels.
Mol. Pharmacol., 2010 Dec , 78 (1088-95).

217

Peretz A et al. Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.
Proc. Natl. Acad. Sci. U.S.A., 2010 Aug 31 , 107 (15637-42).

218

Lee SY et al. Cholesterol inhibits M-type K+ channels via protein kinase C-dependent phosphorylation in sympathetic neurons.
J. Biol. Chem., 2010 Apr 2 , 285 (10939-50).

219

Kotzamanis G et al. CFTR expression from a BAC carrying the complete human gene and associated regulatory elements.
J. Cell. Mol. Med., 2009 Sep , 13 (2938-48).

220

Heron SE et al. Neonatal seizures and Long QT Syndrome: A cardiocerebral channelopathy?
Epilepsia, 2009 Oct 27 , ().

221

Volkers L et al. Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions.
Neurosci. Lett., 2009 Oct 2 , 462 (24-9).

222

Kurahashi H et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures.
Neurology, 2009 Oct 13 , 73 (1214-7).

223

Padilla K et al. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Neurosci. Lett., 2009 Nov 13 , 465 (138-42).

224

Goldberg-Stern H et al. Novel mutation in KCNQ2 causing benign familial neonatal seizures.
Pediatr. Neurol., 2009 Nov , 41 (367-70).

225

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Neurol Clin, 2009 Nov , 27 (1041-61).

226

Hernandez CC et al. Affinity for phosphatidylinositol 4,5-bisphosphate determines muscarinic agonist sensitivity of Kv7 K+ channels.
J. Gen. Physiol., 2009 Nov , 134 (437-48).

227

Lee IC et al. Benign familial neonatal convulsions: novel mutation in a newborn.
Pediatr. Neurol., 2009 May , 40 (387-91).

228

Sugiura Y et al. Lack of potassium current in W309R mutant KCNQ3 channel causing benign familial neonatal convulsions (BFNC).
Epilepsy Res., 2009 Mar , 84 (82-5).

229

Sotty F et al. Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
J. Pharmacol. Exp. Ther., 2009 Mar , 328 (951-62).

230

Miceli F et al. Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures.
Neurobiol. Dis., 2009 Jun , 34 (501-10).

231

Alaimo A et al. Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum.
J. Biol. Chem., 2009 Jul 31 , 284 (20668-75).

232

Villalba-Galea CA et al. Coupling between the voltage-sensing and phosphatase domains of Ci-VSP.
J. Gen. Physiol., 2009 Jul , 134 (5-14).

233

Otto JF et al. Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions.
Epilepsia, 2009 Jul , 50 (1752-9).

234

Ishii A et al. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.
Brain Dev., 2009 Jan , 31 (27-33).

235

Oldfield S et al. Receptor-mediated suppression of potassium currents requires colocalization within lipid rafts.
Mol. Pharmacol., 2009 Dec , 76 (1279-89).

236

Hahn A et al. Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes.
Brain Dev., 2009 Aug , 31 (515-20).

237

Brown DA et al. Neural KCNQ (Kv7) channels.
Br. J. Pharmacol., 2009 Apr , 156 (1185-95).

238

Jensen JB et al. Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phosphoinositides and Kv7.2/7.3 K+ channels.
J. Gen. Physiol., 2009 Apr , 133 (347-59).

239

Jin Z et al. Expression and localization of K channels KCNQ2 and KCNQ3 in the mammalian cochlea.
Audiol. Neurootol., 2009 , 14 (98-105).

240

Mruk K et al. Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes.
PLoS ONE, 2009 , 4 (e4236).

241

Wickenden AD et al. Kv7 channels as targets for the treatment of pain.
Curr. Pharm. Des., 2009 , 15 (1773-98).

242

Roura-Ferrer M et al. Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel.
Cell. Physiol. Biochem., 2009 , 24 (325-34).

243

Blom SM et al. The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes.
PLoS ONE, 2009 , 4 (e8251).

244

Regev N et al. Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity.
PLoS ONE, 2009 , 4 (e6586).

245

Onkal R et al. Alternative splicing of Nav1.5: an electrophysiological comparison of 'neonatal' and 'adult' isoforms and critical involvement of a lysine residue.
J. Cell. Physiol., 2008 Sep , 216 (716-26).

246

Roeloffs R et al. In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models.
J. Pharmacol. Exp. Ther., 2008 Sep , 326 (818-28).

247

Hernandez CC et al. A carboxy-terminal inter-helix linker as the site of phosphatidylinositol 4,5-bisphosphate action on Kv7 (M-type) K+ channels.
J. Gen. Physiol., 2008 Sep , 132 (361-81).

248

Buniel M et al. Distribution of voltage-gated potassium and hyperpolarization-activated channels in sensory afferent fibers in the rat carotid body.
J. Comp. Neurol., 2008 Oct 1 , 510 (367-77).

249

Bal M et al. Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis.
J. Biol. Chem., 2008 Nov 7 , 283 (30668-76).

250

Safiulina VF et al. Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus.
J. Physiol. (Lond.), 2008 Nov 15 , 586 (5437-53).

251

Mackie AR et al. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.
Mol. Pharmacol., 2008 Nov , 74 (1171-9).

252

Bal M et al. Calmodulin binding to M-type K+ channels assayed by TIRF/FRET in living cells.
J. Physiol. (Lond.), 2008 May 1 , 586 (2307-20).

253

Kanaumi T et al. Developmental changes in KCNQ2 and KCNQ3 expression in human brain: possible contribution to the age-dependent etiology of benign familial neonatal convulsions.
Brain Dev., 2008 May , 30 (362-9).

254

Xu C et al. Gonadotropin-releasing hormone (GnRH) activates the m-current in GnRH neurons: an autoregulatory negative feedback mechanism?
Endocrinology, 2008 May , 149 (2459-66).

255

Wickenden AD et al. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Mol. Pharmacol., 2008 Mar , 73 (977-86).

256

Liu B et al. Antihistamine mepyramine directly inhibits KCNQ/M channel and depolarizes rat superior cervical ganglion neurons.
Neuropharmacology, 2008 Mar , 54 (629-39).

257

Li H et al. A novel mutation of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions.
Epilepsy Res., 2008 Mar , 79 (1-5).

258

Uehara A et al. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy.
J. Membr. Biol., 2008 Mar , 222 (55-63).

259

Shah MM et al. Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons.
Proc. Natl. Acad. Sci. U.S.A., 2008 Jun 3 , 105 (7869-74).

260

Hjaeresen ML et al. Chronic electroconvulsive stimulation but not chronic restraint stress modulates mRNA expression of voltage-dependent potassium channels Kv7.2 and Kv11.1 in the rat piriform cortex.
Brain Res., 2008 Jun 27 , 1217 (179-84).

261

Nakajo K et al. Second coiled-coil domain of KCNQ channel controls current expression and subfamily specific heteromultimerization by salt bridge networks.
J. Physiol. (Lond.), 2008 Jun 15 , 586 (2827-40).

262

Singh NA et al. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
J. Physiol. (Lond.), 2008 Jul 15 , 586 (3405-23).

263

Neubauer BA et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.
Neurology, 2008 Jul 15 , 71 (177-83).

264

Liu B et al. Phosphatidylinositol 4,5-bisphosphate hydrolysis mediates histamine-induced KCNQ/M current inhibition.
Am. J. Physiol., Cell Physiol., 2008 Jul , 295 (C81-91).

265

Schuetz F et al. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1.
Am. J. Physiol., Cell Physiol., 2008 Jul , 295 (C73-80).

266

Fedorenko O et al. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.
Psychopharmacology (Berl.), 2008 Jul , 199 (47-54).

267

Wuttke TV et al. Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy.
J. Physiol. (Lond.), 2008 Jan 15 , 586 (545-55).

268

Kim M et al. Ionotropic glutamate receptor expression in preganglionic neurons of the rat inferior salivatory nucleus.
Auton Neurosci, 2008 Feb 29 , 138 (83-90).

269

Xiong Q et al. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
Proc. Natl. Acad. Sci. U.S.A., 2008 Feb 26 , 105 (3128-33).

270

Wladyka CL et al. The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats.
J. Physiol. (Lond.), 2008 Feb 1 , 586 (795-802).

271

Miceli F et al. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
, 2008 Feb , 8 (65-74).

272

Tzingounis AV et al. Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents.
Proc. Natl. Acad. Sci. U.S.A., 2008 Dec 16 , 105 (19974-9).

273

Zaika O et al. Determinants within the turret and pore-loop domains of KCNQ3 K+ channels governing functional activity.
Biophys. J., 2008 Dec , 95 (5121-37).

274

Gao Z et al. Desensitization of chemical activation by auxiliary subunits: convergence of molecular determinants critical for augmenting KCNQ1 potassium channels.
J. Biol. Chem., 2008 Aug 15 , 283 (22649-58).

275

Maingret F et al. Neurotransmitter modulation of small-conductance Ca2+-activated K+ channels by regulation of Ca2+ gating.
Neuron, 2008 Aug 14 , 59 (439-49).

276

Hansen HH et al. Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1823-32).

277

Hernandez CC et al. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1811-21).

278

Maljevic S et al. Nervous system KV7 disorders: breakdown of a subthreshold brake.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1791-801).

279

Etxeberria A et al. Calmodulin regulates the trafficking of KCNQ2 potassium channels.
FASEB J., 2008 Apr , 22 (1135-43).

280

Sadewa AH et al. Germ-line mutation of KCNQ2, p.R213W, in a Japanese family with benign familial neonatal convulsion.
Pediatr Int, 2008 Apr , 50 (167-71).

281

Yalçin O et al. A novel missense mutation (N258S) in the KCNQ2 gene in a Turkish family afflicted with benign familial neonatal convulsions (BFNC).
Turk. J. Pediatr., 2007 Oct-Dec , 49 (385-9).

282

Elghezal H et al. Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4--KCNQ2 genes loci.
Eur J Med Genet, 2007 Nov-Dec , 50 (441-5).

283

Soldovieri MV et al. Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutations.
Channels (Austin), 2007 Jul-Aug , 1 (228-33).

284

Murata Y et al. Depolarization activates the phosphoinositide phosphatase Ci-VSP, as detected in Xenopus oocytes coexpressing sensors of PIP2.
J. Physiol. (Lond.), 2007 Sep 15 , 583 (875-89).

285

Lucarini N et al. Genetic polymorphisms and idiopathic generalized epilepsies.
Pediatr. Neurol., 2007 Sep , 37 (157-64).

286

Hughes S et al. PIP(2)-dependent inhibition of M-type (Kv7.2/7.3) potassium channels: direct on-line assessment of PIP(2) depletion by Gq-coupled receptors in single living neurons.
Pflugers Arch., 2007 Oct , 455 (115-24).

287

Wuttke TV et al. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.
Neurology, 2007 Nov 27 , 69 (2045-53).

288

Qiu C et al. K+ M-current regulates the transition to seizures in immature and adult hippocampus.
Epilepsia, 2007 Nov , 48 (2047-58).

289

Soldovieri MV et al. Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions.
J. Neurosci., 2007 May 2 , 27 (4919-28).

290

Xiong Q et al. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
Nat. Chem. Biol., 2007 May , 3 (287-96).

291

Elmedyb P et al. Modulation of ERG channels by XE991.
Basic Clin. Pharmacol. Toxicol., 2007 May , 100 (316-22).

292

Punke MA et al. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels.
Anesth. Analg., 2007 May , 104 (1256-64, tables of contents).

293

Jia Q et al. Activation of epidermal growth factor receptor inhibits KCNQ2/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation.
J. Neurosci., 2007 Mar 7 , 27 (2503-12).

294

Rasmussen HB et al. Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment.
J. Cell. Sci., 2007 Mar 15 , 120 (953-63).

295

Steinlein OK et al. Benign familial neonatal convulsions: always benign?
Epilepsy Res., 2007 Mar , 73 (245-9).

296

Lerche C et al. Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter.
Mol. Pharmacol., 2007 Jun , 71 (1503-11).

297

Martire M et al. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.
J. Neurochem., 2007 Jul , 102 (179-93).

298

Zhang ZS et al. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
Am. J. Physiol. Heart Circ. Physiol., 2007 Jan , 292 (H399-407).

299

Peretz A et al. Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release.
J. Neurophysiol., 2007 Jan , 97 (283-95).

300

Falace A et al. Inherited neuromyotonia: a clinical and genetic study of a family.
Neuromuscul. Disord., 2007 Jan , 17 (23-7).

301

Hu H et al. M-channels (Kv7/KCNQ channels) that regulate synaptic integration, excitability, and spike pattern of CA1 pyramidal cells are located in the perisomatic region.
J. Neurosci., 2007 Feb 21 , 27 (1853-67).

302

Hirano K et al. Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice.
Neurosci. Lett., 2007 Feb 14 , 413 (159-62).

303

Heron SE et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.
J. Med. Genet., 2007 Dec , 44 (791-6).

304

Jow F et al. Validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel enhancers using IonWorks HT.
, 2007 Dec , 12 (1059-67).

305

Xu T et al. Roles of alternative splicing in the functional properties of inner ear-specific KCNQ4 channels.
J. Biol. Chem., 2007 Aug 17 , 282 (23899-909).

306

Brown DA et al. Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition.
J. Physiol. (Lond.), 2007 Aug 1 , 582 (917-25).

307

Ekberg J et al. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by ubiquitination. Novel role for Nedd4-2.
J. Biol. Chem., 2007 Apr 20 , 282 (12135-42).

308

Crozier RA et al. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability.
J. Neurosci., 2007 Apr 18 , 27 (4492-6).

309

Wehling C et al. Self-assembly of the isolated KCNQ2 subunit interaction domain.
FEBS Lett., 2007 Apr 17 , 581 (1594-8).

310

Jensen HS et al. Inactivation as a new regulatory mechanism for neuronal Kv7 channels.
Biophys. J., 2007 Apr 15 , 92 (2747-56).

311

Borsotto M et al. PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder.
Pharmacogenomics J., 2007 Apr , 7 (123-32).

312

Peretz A et al. A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives.
PLoS ONE, 2007 , 2 (e1332).

313

Murphy SM et al. Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel.
, 2006 Jul-Aug , 54 (42-55).

314

Zimprich F et al. Andreas Rett and benign familial neonatal convulsions revisited.
Neurology, 2006 Sep 12 , 67 (864-6).

315

Zhou X et al. Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2.
Eur. J. Pediatr., 2006 Oct , 165 (691-5).

316

Hunter J et al. Subthreshold changes of voltage-dependent activation of the K(V)7.2 channel in neonatal epilepsy.
Neurobiol. Dis., 2006 Oct , 24 (194-201).

317

Lawrence JJ et al. Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons.
J. Neurosci., 2006 Nov 22 , 26 (12325-38).

318

Bentzen BH et al. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Neuropharmacology, 2006 Nov , 51 (1068-77).

319

Richter A et al. Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia.
Br. J. Pharmacol., 2006 Nov , 149 (747-53).

320

Geiger J et al. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain.
Neurosci. Lett., 2006 May 29 , 400 (101-4).

321

Schwarz JR et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier.
J. Physiol. (Lond.), 2006 May 15 , 573 (17-34).

322

de Haan GJ et al. A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years.
Epilepsia, 2006 May , 47 (851-9).

323

Pan Z et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon.
J. Neurosci., 2006 Mar 8 , 26 (2599-613).

324

Seebohm G et al. Differential roles of S6 domain hinges in the gating of KCNQ potassium channels.
Biophys. J., 2006 Mar 15 , 90 (2235-44).

325

Kearney JA et al. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
Hum. Mol. Genet., 2006 Mar 15 , 15 (1043-8).

326

Weber YG et al. Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain.
Brain Res., 2006 Mar 10 , 1077 (1-6).

327

Coppola G et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy.
Brain Dev., 2006 Mar , 28 (76-9).

328

Chung HJ et al. Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains.
Proc. Natl. Acad. Sci. U.S.A., 2006 Jun 6 , 103 (8870-5).

329

Robbins J et al. Probing the regulation of M (Kv7) potassium channels in intact neurons with membrane-targeted peptides.
J. Neurosci., 2006 Jul 26 , 26 (7950-61).

330

Zhou XH et al. [A novel mutation in KCNQ2 gene causes benign familial infantile convulsions (BFIC) in a Chinese family]
Zhonghua Er Ke Za Zhi, 2006 Jul , 44 (487-91).

331

Soldovieri MV et al. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions.
J. Biol. Chem., 2006 Jan 6 , 281 (418-28).

332

Peña F et al. Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro.
Epilepsia, 2006 Jan , 47 (47-54).

333

Otto JF et al. A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons.
J. Neurosci., 2006 Feb 15 , 26 (2053-9).

334

Jow F et al. Validation of DRG-like F11 cells for evaluation of KCNQ/M-channel modulators.
, 2006 Feb , 4 (49-56).

335

Miura K et al. Membrane channel properties of premotor excitatory burst neurons may underlie saccade slowing after lesions of omnipause neurons.
, 2006 Feb , 20 (25-41).

336

Suh BC et al. Does diacylglycerol regulate KCNQ channels?
Pflugers Arch., 2006 Dec , 453 (293-301).

337

Gardiner M Molecular genetics of infantile nervous system channelopathies.
Early Hum. Dev., 2006 Dec , 82 (775-9).

338

Ferraro TN et al. Role of genetics in the diagnosis and treatment of epilepsy.
, 2006 Dec , 6 (1789-800).

339

Zaika O et al. Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels.
J. Physiol. (Lond.), 2006 Aug 15 , 575 (49-67).

340

Wladyka CL et al. KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons.
J. Physiol. (Lond.), 2006 Aug 15 , 575 (175-89).

341

Li HY et al. [Clinical and mutational analysis of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Aug , 23 (374-7).

342

Schwake M et al. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
J. Neurosci., 2006 Apr 5 , 26 (3757-66).

343

Liang GH et al. Molecular analyses of KCNQ1-5 potassium channel mRNAs in rat and guinea pig inner ears: expression, cloning, and alternative splicing.
Acta Otolaryngol., 2006 Apr , 126 (346-52).

344

Hayashi T et al. Ca2+ transient induced by extracellular changes in osmotic pressure in Arabidopsis leaves: differential involvement of cell wall-plasma membrane adhesion.
Plant Cell Environ., 2006 Apr , 29 (661-72).

345

Strutz-Seebohm N et al. Functional coassembly of KCNQ4 with KCNE-beta- subunits in Xenopus oocytes.
Cell. Physiol. Biochem., 2006 , 18 (57-66).

346

Blackburn-Munro G et al. Retigabine: chemical synthesis to clinical application.
, 2005 Spring , 11 (1-20).

347

Li Y et al. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
J. Neurosci., 2005 Oct 26 , 25 (9825-35).

348

Shahidullah M et al. Expression of a calmodulin-binding KCNQ2 potassium channel fragment modulates neuronal M-current and membrane excitability.
Proc. Natl. Acad. Sci. U.S.A., 2005 Nov 8 , 102 (16454-9).

349

Penschuck S et al. Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy.
Brain Res. Mol. Brain Res., 2005 Nov 18 , 141 (66-73).

350

Nakajo K et al. Protein kinase C shifts the voltage dependence of KCNQ/M channels expressed in Xenopus oocytes.
J. Physiol. (Lond.), 2005 Nov 15 , 569 (59-74).

351

Schenzer A et al. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
J. Neurosci., 2005 May 18 , 25 (5051-60).

352

Winks JS et al. Relationship between membrane phosphatidylinositol-4,5-bisphosphate and receptor-mediated inhibition of native neuronal M channels.
J. Neurosci., 2005 Mar 30 , 25 (3400-13).

353

Lan WZ et al. Electrophysiological and molecular identification of hepatocellular volume-activated K+ channels.
Biochim. Biophys. Acta, 2005 Mar 1 , 1668 (223-33).

354

Wang X et al. [Advances in the studies on the molecular and genetic aspects of epilepsy]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2005 Jun , 27 (388-93).

355

Wolff C et al. [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.
Eur. J. Pharmacol., 2005 Jul 25 , 518 (10-7).

356

Pinto D et al. Gene symbol: KCNQ2. Disease: Benign neonatal familial convulsion.
Hum. Genet., 2005 Jul , 117 (300).

357

Schmitt B et al. Neonatal seizures with tonic clonic sequences and poor developmental outcome.
Epilepsy Res., 2005 Jul , 65 (161-8).

358

Surti TS et al. A potassium channel, the M-channel, as a therapeutic target.
, 2005 Jul , 6 (704-11).

359

L'Heureux A et al. (S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity.
Bioorg. Med. Chem. Lett., 2005 Jan 17 , 15 (363-6).

360

Peters HC et al. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.
Nat. Neurosci., 2005 Jan , 8 (51-60).

361

Devaux JJ et al. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA.
J. Neurosci., 2005 Feb 9 , 25 (1470-80).

362

Surti TS et al. Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels.
Proc. Natl. Acad. Sci. U.S.A., 2005 Dec 6 , 102 (17828-33).

363

Bassi MT et al. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC).
Neurogenetics, 2005 Dec , 6 (185-93).

364

Shen W et al. Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons.
J. Neurosci., 2005 Aug 10 , 25 (7449-58).

365

Gamper N et al. Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+/calmodulin.
Mol. Biol. Cell, 2005 Aug , 16 (3538-51).

366

Peretz A et al. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
Mol. Pharmacol., 2005 Apr , 67 (1053-66).

367

Wuttke TV et al. The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate.
Mol. Pharmacol., 2005 Apr , 67 (1009-17).

368

Wua YJ et al. Recent developments on KCNQ potassium channel openers.
Curr. Med. Chem., 2005 , 12 (453-60).

369

Liang G et al. An M-like potassium current in the guinea pig cochlea.
ORL J. Otorhinolaryngol. Relat. Spec., 2005 , 67 (75-82).

370

Seebohm G et al. Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes.
Cell. Physiol. Biochem., 2005 , 16 (255-62).

371

Gardiner M Genetics of idiopathic generalized epilepsies.
Epilepsia, 2005 , 46 Suppl 9 (15-20).

372

Burgess DL Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
Epilepsia, 2005 , 46 Suppl 10 (51-8).

373

Wu YJ et al. Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides.
Bioorg. Med. Chem. Lett., 2004 Sep 6 , 14 (4533-7).

374

Otto JF et al. Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
Epilepsia, 2004 Sep , 45 (1009-16).

375

Li Y et al. Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase.
J. Biol. Chem., 2004 Oct 29 , 279 (45399-407).

376

Etxeberria A et al. Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.
J. Neurosci., 2004 Oct 13 , 24 (9146-52).

377

Wang K et al. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
, 2004 Oct , 2 (525-34).

378

Wu YJ et al. Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers.
J. Med. Chem., 2004 May 20 , 47 (2887-96).

379

Kelemen A et al. [Genetic background of epilepsies]
, 2004 May 20 , 57 (141-51).

380

Richards MC et al. Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction.
J. Med. Genet., 2004 Mar , 41 (e35).

381

Prole DL et al. Ionic permeation and conduction properties of neuronal KCNQ2/KCNQ3 potassium channels.
Biophys. J., 2004 Mar , 86 (1454-69).

382

Li Y et al. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
J. Neurosci., 2004 Jun 2 , 24 (5079-90).

383

Tang B et al. A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family.
J. Neurol. Sci., 2004 Jun 15 , 221 (31-4).

384

Suh BC et al. Regulation of KCNQ2/KCNQ3 current by G protein cycling: the kinetics of receptor-mediated signaling by Gq.
J. Gen. Physiol., 2004 Jun , 123 (663-83).

385

Borgatti R et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation.
Neurology, 2004 Jul 13 , 63 (57-65).

386

Martire M et al. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
J. Neurosci., 2004 Jan 21 , 24 (592-7).

387

Devaux JJ et al. KCNQ2 is a nodal K+ channel.
J. Neurosci., 2004 Feb 4 , 24 (1236-44).

388

Claes LR et al. De novo KCNQ2 mutations in patients with benign neonatal seizures.
Neurology, 2004 Dec 14 , 63 (2155-8).

389

Punke MA et al. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
Anesthesiology, 2004 Aug , 101 (430-8).

390

Hewawasam P et al. The synthesis and structure-activity relationships of 3-amino-4-benzylquinolin-2-ones; discovery of novel KCNQ2 channel openers.
Bioorg. Med. Chem. Lett., 2004 Apr 5 , 14 (1615-8).

391

Wu YJ et al. (S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neurons.
Bioorg. Med. Chem. Lett., 2004 Apr 19 , 14 (1991-5).

392

Pereira S et al. Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign neonatal convulsions or other epileptic phenotypes.
Epilepsia, 2004 Apr , 45 (384-90).

393

Vickery RG et al. Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR.
Recept. Channels, 2004 , 10 (11-23).

394

Tatulian L et al. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.
J. Physiol. (Lond.), 2003 May 15 , 549 (57-63).

395

Yang Y et al. Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold.
Hum. Mol. Genet., 2003 May 1 , 12 (975-84).

396

Zhang H et al. PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents.
Neuron, 2003 Mar 27 , 37 (963-75).

397

Ford CP et al. Experiments to test the role of phosphatidylinositol 4,5-bisphosphate in neurotransmitter-induced M-channel closure in bullfrog sympathetic neurons.
J. Neurosci., 2003 Jun 15 , 23 (4931-41).

398

Hadley JK et al. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.
J. Neurosci., 2003 Jun 15 , 23 (5012-9).

399

Grunnet M et al. KCNQ1 channels sense small changes in cell volume.
J. Physiol. (Lond.), 2003 Jun 1 , 549 (419-27).

400

Hoshi N et al. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists.
Nat. Neurosci., 2003 Jun , 6 (564-71).

401

Coppola G et al. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes.
Neurology, 2003 Jul 8 , 61 (131-4).

402

Zhang ZH et al. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Brain Res. Mol. Brain Res., 2003 Jul 4 , 115 (29-38).

403

Wu YJ et al. (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine.
J. Med. Chem., 2003 Jul 17 , 46 (3197-200).

404

Gamper N et al. Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels.
J. Gen. Physiol., 2003 Jul , 122 (17-31).

405

Seebohm G et al. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Mol. Pharmacol., 2003 Jul , 64 (70-7).

406

Gamper N et al. Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase.
J. Neurosci., 2003 Jan 1 , 23 (84-95).

407

Schwake M et al. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.
EMBO Rep., 2003 Jan , 4 (76-81).

408

Guo J et al. Activation of muscarinic m5 receptors inhibits recombinant KCNQ2/KCNQ3 K+ channels expressed in HEK293T cells.
Eur. J. Pharmacol., 2003 Feb 21 , 462 (25-32).

409

Okada M et al. Age-dependent modulation of hippocampal excitability by KCNQ-channels.
Epilepsy Res., 2003 Feb , 53 (81-94).

410

Singh NA et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
Brain, 2003 Dec , 126 (2726-37).

411

Prole DL et al. Mechanisms underlying modulation of neuronal KCNQ2/KCNQ3 potassium channels by extracellular protons.
J. Gen. Physiol., 2003 Dec , 122 (775-93).

412

Gribkoff VK The therapeutic potential of neuronal KCNQ channel modulators.
Expert Opin. Ther. Targets, 2003 Dec , 7 (737-48).

413

Li HY et al. [A novel mutation of KCNQ2 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003 Dec , 20 (482-5).

414

Passmore GM et al. KCNQ/M currents in sensory neurons: significance for pain therapy.
J. Neurosci., 2003 Aug 6 , 23 (7227-36).

415

Wu YJ et al. Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibiti
J. Med. Chem., 2003 Aug 28 , 46 (3778-81).

416

Scott CW et al. A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.
Anal. Biochem., 2003 Aug 15 , 319 (251-7).

417

Maljevic S et al. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
J. Physiol. (Lond.), 2003 Apr 15 , 548 (353-60).

418

Cooper EC et al. M-channels: neurological diseases, neuromodulation, and drug development.
Arch. Neurol., 2003 Apr , 60 (496-500).

419

Dedek K et al. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2.
Epilepsy Res., 2003 Apr , 54 (21-7).

420

Yus-Nájera E et al. Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation.
Neuroscience, 2003 , 120 (353-64).

421

Lubec G et al. RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain.
J. Neural Transm. Suppl., 2003 , (215-24).

422

Wen H et al. Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels.
J. Neurosci., 2002 Sep 15 , 22 (7991-8001).

423

Chou IC et al. The voltage-gated potassium channel KCNQ2 in Taiwanese children with febrile convulsions.
Neuroreport, 2002 Oct 28 , 13 (1971-3).

424

Shah MM et al. Molecular correlates of the M-current in cultured rat hippocampal neurons.
J. Physiol. (Lond.), 2002 Oct 1 , 544 (29-37).

425

Grant AO et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.
J. Clin. Invest., 2002 Oct , 110 (1201-9).

426

Grunnet M et al. KCNE4 is an inhibitory subunit to the KCNQ1 channel.
J. Physiol. (Lond.), 2002 Jul 1 , 542 (119-30).

427

Castaldo P et al. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels.
J. Neurosci., 2002 Jan 15 , 22 (RC199).

428

Guo J et al. Activation of a PTX-insensitive G protein is involved in histamine-induced recombinant M-channel modulation.
J. Physiol. (Lond.), 2002 Dec 15 , 545 (767-81).

429

Chioza B et al. Suggestive evidence for association of two potassium channel genes with different idiopathic generalised epilepsy syndromes.
Epilepsy Res., 2002 Dec , 52 (107-16).

430

Roche JP et al. Antibodies and a cysteine-modifying reagent show correspondence of M current in neurons to KCNQ2 and KCNQ3 K+ channels.
Br. J. Pharmacol., 2002 Dec , 137 (1173-86).

431

Wickenden AD Potassium channels as anti-epileptic drug targets.
Neuropharmacology, 2002 Dec , 43 (1055-60).

432

Yus-Najera E et al. The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels.
J. Biol. Chem., 2002 Aug 9 , 277 (28545-53).

433

Guo J et al. Histamine inhibits KCNQ2/KCNQ3 channel current via recombinant histamine H(1) receptors.
Neurosci. Lett., 2002 Aug 16 , 328 (285-8).

434

Suh BC et al. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis.
Neuron, 2002 Aug 1 , 35 (507-20).

435

Steinlein OK Channelopathies can cause epilepsy in man.
, 2002 , 6 Suppl A (27-34).

436

Kaneko S et al. Genetic identifiers of epilepsy.
Epilepsia, 2002 , 43 Suppl 9 (16-20).

437

Okada M et al. Impaired M-current and neuronal excitability.
Epilepsia, 2002 , 43 Suppl 9 (36-8).

438

Pfohl JL et al. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction.
Recept. Channels, 2002 , 8 (99-111).

439

Serrano-Castro PJ et al. [Ring chromosome 20: an epileptic channel disorder?]
Rev Neurol, 2001 Feb 1-15 , 32 (237-41).

440

Steinlein OK Genes and mutations in idiopathic epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (139-45).

441

Lerche H et al. Ion channels and epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (146-59).

442

Dedek K et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.
Proc. Natl. Acad. Sci. U.S.A., 2001 Oct 9 , 98 (12272-7).

443

Meissner P et al. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells.
Biotechnol. Bioeng., 2001 Oct 20 , 75 (197-203).

444

MacVinish LJ et al. Xe991 reveals differences in K(+) channels regulating chloride secretion in murine airway and colonic epithelium.
Mol. Pharmacol., 2001 Oct , 60 (753-60).

445

Moulard B et al. Ion channel variation causes epilepsies.
Brain Res. Brain Res. Rev., 2001 Oct , 36 (275-84).

446

Korolkova YV et al. An ERG channel inhibitor from the scorpion Buthus eupeus.
J. Biol. Chem., 2001 Mar 30 , 276 (9868-76).

447

Pan Z et al. Alternative splicing of KCNQ2 potassium channel transcripts contributes to the functional diversity of M-currents.
J. Physiol. (Lond.), 2001 Mar 1 , 531 (347-58).

448

Schrøder RL et al. KCNQ4 channel activation by BMS-204352 and retigabine.
Neuropharmacology, 2001 Jun , 40 (888-98).

449

Saganich MJ et al. Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain.
J. Neurosci., 2001 Jul 1 , 21 (4609-24).

450

Selyanko AA et al. Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.
J. Physiol. (Lond.), 2001 Jul 1 , 534 (15-24).

451

Yamakura T et al. Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels.
Anesthesiology, 2001 Jul , 95 (144-53).

452

Smith JS et al. Differential expression of kcnq2 splice variants: implications to m current function during neuronal development.
J. Neurosci., 2001 Feb 15 , 21 (1096-103).

453

Xiao JF et al. Cloning and mutation analysis of the human potassium channel KCNQ2 gene promoter.
Neuroreport, 2001 Dec 4 , 12 (3733-9).

454

Cooper EC et al. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain.
J. Neurosci., 2001 Dec 15 , 21 (9529-40).

455

Yin H et al. Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein.
Cytokine, 2001 Aug 7 , 15 (122-37).

456

Tatulian L et al. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
J. Neurosci., 2001 Aug 1 , 21 (5535-45).

457

Seebohm G et al. Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome.
J. Biol. Chem., 2001 Apr 27 , 276 (13600-5).

458

Robbins J KCNQ potassium channels: physiology, pathophysiology, and pharmacology.
Pharmacol. Ther., 2001 Apr , 90 (1-19).

459

Cooper EC Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs.
Epilepsia, 2001 , 42 Suppl 5 (49-54).

460

Jow F et al. Cloning and functional expression of rKCNQ2 K(+) channel from rat brain.
Brain Res. Mol. Brain Res., 2000 Sep 15 , 80 (269-78).

461

Tinel N et al. M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit.
FEBS Lett., 2000 Sep 1 , 480 (137-41).

462

Rogawski MA KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy.
Trends Neurosci., 2000 Sep , 23 (393-8).

463

Wickenden AD et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
Mol. Pharmacol., 2000 Sep , 58 (591-600).

464

Zhu G et al. Dysfunction of M-channel enhances propagation of neuronal excitability in rat hippocampus monitored by multielectrode dish and microdialysis systems.
Neurosci. Lett., 2000 Nov 10 , 294 (53-7).

465

Haug K et al. No evidence for association between the KCNQ3 gene and susceptibility to idiopathic generalized epilepsy.
Epilepsy Res., 2000 Nov , 42 (57-62).

466

Schwake M et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy.
J. Biol. Chem., 2000 May 5 , 275 (13343-8).

467

Gardiner RM Impact of our understanding of the genetic aetiology of epilepsy.
J. Neurol., 2000 May , 247 (327-34).

468

Barrantes FJ et al. The neuronal nicotinic acetylcholine receptor in some hereditary epilepsies.
Neurochem. Res., 2000 May , 25 (583-90).

469

Rundfeldt C et al. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.
Neurosci. Lett., 2000 Mar 17 , 282 (73-6).

470

Shapiro MS et al. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.
J. Neurosci., 2000 Mar 1 , 20 (1710-21).

471

Huertas D et al. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells.
Hum. Mol. Genet., 2000 Mar 1 , 9 (617-29).

472

Kananura C et al. The new voltage gated potassium channel KCNQ5 and neonatal convulsions.
Neuroreport, 2000 Jun 26 , 11 (2063-7).

473

Wang HS et al. Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991.
Mol. Pharmacol., 2000 Jun , 57 (1218-23).

474

Hirose S et al. A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions.
Ann. Neurol., 2000 Jun , 47 (822-6).

475

Watanabe H et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability.
J. Neurochem., 2000 Jul , 75 (28-33).

476

Selyanko AA et al. Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.
J. Physiol. (Lond.), 2000 Feb 1 , 522 Pt 3 (349-55).

477

Nörenberg W et al. M-type K+ currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release.
Br. J. Pharmacol., 2000 Feb , 129 (709-23).

478

Hadley JK et al. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
Br. J. Pharmacol., 2000 Feb , 129 (413-5).

479

Lee WL et al. A KCNQ2 splice site mutation causing benign neonatal convulsions in a Scottish family.
Neuropediatrics, 2000 Feb , 31 (9-12).

480

Miraglia del Giudice E et al. Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor.
Eur. J. Hum. Genet., 2000 Dec , 8 (994-7).

481

Higashida H et al. Both linopirdine- and WAY123,398-sensitive components of I K(M,ng) are modulated by cyclic ADP ribose in NG108-15 cells.
Pflugers Arch., 2000 Dec , 441 (228-34).

482

Schroeder BC et al. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.
J. Biol. Chem., 2000 Aug 4 , 275 (24089-95).

483

Main MJ et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Mol. Pharmacol., 2000 Aug , 58 (253-62).

484

Steinlein OK [Benign familial neonatal convulsions: molecular pathology and diagnosis]
, 2000 Aug , 71 (611-5).

485

Cooper EC et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.
Proc. Natl. Acad. Sci. U.S.A., 2000 Apr 25 , 97 (4914-9).

486

Tolmachova T et al. Analysis of a YAC with human telomeres and oriP from epstein-barr virus in yeast and 293 cells.
Nucleic Acids Res., 1999 Sep 15 , 27 (3736-44).

487

Selyanko AA et al. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.
J. Neurosci., 1999 Sep 15 , 19 (7742-56).

488

Lerche H et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions.
Ann. Neurol., 1999 Sep , 46 (305-12).

489

Rho JM et al. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
Dev. Neurosci., 1999 Nov , 21 (320-7).

490

McCormack T et al. Chromosomal mapping of the potassium channel genes Kcnq2 and Kcnq3 in mouse.
Genomics, 1999 Mar 15 , 56 (360-1).

491

Biervert C et al. Structural and mutational analysis of KCNQ2, the major gene locus for benign familial neonatal convulsions.
Hum. Genet., 1999 Mar , 104 (234-40).

492

Meves H et al. Separation of M-like current and ERG current in NG108-15 cells.
Br. J. Pharmacol., 1999 Jul , 127 (1213-23).

493

Hirsch E et al. [Benign familial neonatal convulsions: a model of idiopathic epilepsy]
Rev. Neurol. (Paris), 1999 Jul , 155 (463-7).

494

Steinlein OK et al. The voltage gated potassium channel KCNQ2 and idiopathic generalized epilepsy.
Neuroreport, 1999 Apr 26 , 10 (1163-6).

495

Steinlein OK Idiopathic epilepsies with a monogenic mode of inheritance.
Epilepsia, 1999 , 40 Suppl 3 (9-11).

496

Leppert MF et al. Susceptibility genes in human epilepsy.
, 1999 , 19 (397-405).

497

Tinel N et al. The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3.
FEBS Lett., 1998 Nov 6 , 438 (171-6).

498

Steinlein OK et al. KCNQ2, the first gene found to be mutated in human generalized idiopathic epilepsy.
Pathol. Biol., 1998 Nov , 46 (683-4).

499

Yang WP et al. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy.
J. Biol. Chem., 1998 Jul 31 , 273 (19419-23).

500

Biervert C et al. A potassium channel mutation in neonatal human epilepsy.
Science, 1998 Jan 16 , 279 (403-6).

501

Charlier C et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.
Nat. Genet., 1998 Jan , 18 (53-5).

502

Singh NA et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
Nat. Genet., 1998 Jan , 18 (25-9).

503

Wang HS et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
Science, 1998 Dec 4 , 282 (1890-3).

504

Schroeder BC et al. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
Nature, 1998 Dec 17 , 396 (687-90).

505

Nakamura M et al. KQT2, a new putative potassium channel family produced by alternative splicing. Isolation, genomic structure, and alternative splicing of the putative potassium channels.
Recept. Channels, 1998 , 5 (255-71).

506

Terwindt GM et al. Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome.
Epilepsia, 1997 Aug , 38 (915-21).

507

Lewis TB et al. Localization of a gene for a glutamate binding subunit of a NMDA receptor (GRINA) to 8q24.
Genomics, 1996 Feb 15 , 32 (131-3).

508

Phillips HA et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2.
Nat. Genet., 1995 May , 10 (117-8).

509

Steinlein O Detection of a CfoI polymorphism within exon 5 of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4).
Hum. Genet., 1995 Jul , 96 (130).

510

Melis R et al. Physical and genetic localization of a Shab subfamily potassium channel (KCNB1) gene to chromosomal region 20q13.2.
Genomics, 1995 Jan 1 , 25 (285-7).

511

Beck C et al. A nonsense mutation in the alpha4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI)
Neurobiol. Dis., 1994 Nov , 1 (95-9).

512

Bear MF et al. Glutamic acid decarboxylase in the striate cortex of normal and monocularly deprived kittens.
J. Neurosci., 1985 May , 5 (1262-75).